Iterum Therapeutics Reports First Quarter 2025 Financial Results
Iterum Therapeutics(US:ITRM) Globenewswire·2025-05-13 11:00--Preparing for Potential Launch of ORLYNVAH by Q4 2025-- --Extended Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial results for the first quarter ended March 31, 2025. "Based on pr ...